WMB
64
-4
SEE
41
-7
URBN
54
-6
OMC
61
-3
PPG
58
-2
DHR
52
-4
LNC
35
-5
APD
44
-10
MMM
33
-4
MTCH
24
-7
STT
53
-3
LH
50
-5
TROW
34
-3
HRB
73
-5
AVGO
25
3
PRU
48
-2
SCHW
62
-2
SRE
45
-18
ZBH
59
-3
PEP
54
-6
WMB
64
-4
SEE
41
-7
URBN
54
-6
OMC
61
-3
PPG
58
-2
DHR
52
-4
LNC
35
-5
APD
44
-10
MMM
33
-4
MTCH
24
-7
STT
53
-3
LH
50
-5
TROW
34
-3
HRB
73
-5
AVGO
25
3
PRU
48
-2
SCHW
62
-2
SRE
45
-18
ZBH
59
-3
PEP
54
-6
Financhill
Back

Zimmer Biomet Holdings 10K Form

Buy
59

ZBH
Zimmer Biomet Holdings

Last Price:
116.14
Seasonality Move:
7.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZBH News And Ratings

See the #1 stock for the next 7 days that we like better than ZBH

ZBH Financial Statistics

Sales & Book Value

Annual Sales: $6.94B
Cash Flow: $240.2M
Price / Cash Flow: 28.34
Annual Sales: $59.86
Price / Book: 1.93

Profitability

EPS (TTM): 2.26000
Net Income (TTM): $474.3M
Gross Margin: $4.92B
Return on Equity: 3.87%
Return on Assets: 2.23%

Zimmer Biomet Holdings Earnings Forecast

Key Zimmer Biomet Holdings Financial Ratios

  • The Gross Profit Margin over the past 23 years for ZBH is 70.90%.
  • The Selling, General & Administrative Expenses for ZBH have been equal to 39.79% of Gross Profit Margin.
  • The Research & Development expenses have been 5.85% of Revenue.
  • The Interest Expense is 71.22% of Operating Income.
  • The Net Earning history of ZBH is 3.33% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

Zimmer Biomet Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Medical Devices
Sector: Healthcare
Current Symbol: ZBH
CUSIP: 98956P
Website: zimmerbiomet.com

Debt

Debt-to-Equity Ratio: 0.45
Current Ratio: 2.11
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 105.29
Forward P/E Ratio: 14.58

ZBH Technical Analysis vs Fundamental Analysis

Buy
59
Zimmer Biomet Holdings (ZBH) is a Buy

Is Zimmer Biomet Holdings a Buy or a Sell?